Investing

Generation Bio : GBIO

GBIO

Stock Data

$5.34

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Generation Bio Co. is a pioneering genetic medicines company based in Cambridge, Massachusetts. Founded in 2016 and originally known as Torus Therapeutics, Inc., it focuses on developing innovative therapies for a wide range of diseases, including those affecting the liver, retina, skeletal muscle, central nervous system, and even cancer. With a commitment to addressing both rare and prevalent conditions, Generation Bio Co. is at the forefront of leveraging genetic insights to improve patient outcomes.